Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2026-02-20 @ 2:57 AM
Study NCT ID:
NCT02695992
Status:
COMPLETED
Last Update Posted:
2022-01-05
First Post:
2015-04-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rate Control in Atrial Fibrillation II
Sponsor:
Asker & Baerum Hospital
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Rate control in atrial fibrillation | View |
| None | Beta blockers | View |
| None | Calcium channel blockers | View |
| None | Permanent atrial fibrillation | View |
| None | Management of atrial fibrillation | View |
| None | Atrial fibrillation and biomarkers | View |
| None | Arrhythmias, cardiac | View |
| None | Heart Diseases | View |
| None | Pathological processes | View |
| None | Diltiazem | View |
| None | Metoprolol | View |
| None | Adrenergic Agents | View |
| None | Adrenergic Antagonists | View |
| None | Adrenergic beta-1 Receptor Antagonists | View |
| None | Adrenergic beta-Antagonists | View |
| None | Anti-Arrhythmia Agents | View |
| None | Antihypertensive Agents | View |
| None | Autonomic Agents | View |
| None | Cardiovascular Agents | View |
| None | Membrane Transport Modulators | View |
| None | Molecular Mechanisms of Pharmacological Action | View |
| None | Neurotransmitter Agents | View |
| None | Peripheral Nervous System Agents | View |
| None | Physiological Effects of Drugs | View |
| None | Sympatholytics | View |
| None | Therapeutic Uses | View |
| None | Vasodilator Agents | View |
| None | Troponins | View |
| None | NT-proBNP | View |
| None | Biomarkers | View |